Tech stocks drive market gains, healthcare falters: A sector breakdown
Tech stocks drive market gains, healthcare falters: A sector breakdown Today’s US stock market showcased a dynamic landscape…
Doctor Ignored Signs Of Cancer
Most doctors are intelligent, compassionate human beings, but they are human. And medicine is a business, which means…
‘Especially challenging’: Sault hospital sees surge of flu cases
In face of emerging H3N2 strain, SAH has ‘more pediatric cases, increased hospital visits, more severe symptoms, and…
Pediatric nurse practitioner joins Atracare clinical team
Atracare recently welcomed Christina Minissale, CRNP, to its growing pediatric team. Minissale brings advanced training and a broad…
Wegovy Pill Becomes First Oral GLP-1 Weight-Loss Drug Approved in U.S.
December 23, 2025 3 min read Add Us On GoogleAdd SciAm U.S. Approves Wegovy Weight-Loss Pill, a Move…
NHS Forth Valley lift visiting restrictions imposed after ‘sharp and early’ rise in flu
Hospital chiefs have lifted visiting restrictions imposed after a sharp and early rise in seasonal flu in NHS…
These 2 Healthcare Stocks Just Declared Dividend Raises
The healthcare industry has never been a great source of dividends — that alone makes these companies exceptional.…
Jun Hyun Moo’s Medical Records Released Amid “Injection Auntie” Accusations
Broadcaster Jun Hyun Moo has released medical records regarding intravenous treatment in a vehicle, refuting related suspicions. On…
America’s Health Care System Broke in 2025
Two moments in 2025 revealed how vulnerable the U.S. health care system has become. The first was quiet…
Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill…
Why Medicaid programs are cutting back on a popular therapy for autism : Shots
Just months ago, Gaile Osborne (left) didn’t expect her adoptive 3-year-old daughter, Aubreigh, would make friends at school.…
Eight Roads-backed PlasmaGen Bio snags funding, valuation nears $170 mn
Plasmagen Biosciences CEO Vivek Kamath PlasmaGen Biosciences, a biopharmaceutical company which counts investors such as Eight Roads Ventures…